Money is dear to all, earning money is one thing and thinking then where to invest is another. Now the best option to invest your money is the private equity. There returns are high for the investors. Quadria Capital is a private healthcare equity firms with assets over 1.5 billion dollars and investing across 18 different countries across Asia- Pacific region.

Quadria Capital is currently the largest equity firms in Asia but their main aim is to partner with promising regional healthcare companies and, with our active investment strategy, help them grow as regional leaders and create outstanding returns to the investors. By this way we are able to benefit both the investors and society. With investing in healthcare we are able to change the conditions of healthcare facilities in various countries.
Our approach has always been to find the promising regional healthcare companies within Asia, because over the past decade the global hub for healthcare is been shifting to Asia. Before investing in any regional company we first try to understand the local and regional fundamentals of healthcare industry in that country. The main is to have meaningful and sustainable impact on the life and side by side creating values to the investors.

The firm has invested in India by partnering with leading healthcare group to benefits the life of the people and creating value to itself and its investors. The various partners are:

• Krishna Institute of Medical Science Ltd.
• Healthcare at Home India
• Healthcare Global Enterprises Ltd.
• Krishna Institute Of Medical Science
• Medical Superspeciality Hospital
• Asian Institute Of Gastroentrology

Apart from investing within India the company has gone global by partnering with leading diagnostic provide in Malaysia. The partnership will also allow Quadria Capital to support Lablink’s growth in the Malaysian market and its diversification across Southeast Asia. With over 400 service staff, Lablink offers high quality diagnostic services through operating its central laboratory, as well as managing the hospital laboratories for KPJ Group hospitals. Its comprehensive service offerings include haematology, chemical pathology, immunology & serology, histology, biosafety & mycobacteriology, medical microbiology, cytology, molecular diagnostics, and health screening packages.

Apart from Malaysia, Quadria Capital has invested in various healthcare groups from Singapore like MWH Holdings and Concord Biotech and are planning to expand more in the near future. By this they slowly and steadily capture the Asian market, maximize their returns and grow their equity firm in terms of value.

We firmly believe that our actions will have an impact over the society and the way people live their lives. So, we believe that addressing the environmental, social and governance is just only the right thing to do, but important for sustainable and long-term value creation.

Our other focus zones beside being a regional leader in the Asian market, we also need to have a strong stable free cash flow, then should have experienced and qualified management team who understands the regional problems and provide quick solutions.

We would like to continue like this in future and help in building the society and creating positive social impacts. Our reputation as an individual and as a firm is our key to success.

We immensely value the support of our investors and remain focused, and driven, to reward and repay their trust in Quadria Capital.